Cameron Ortis, the senior RCMP director accused of preparing to leak sensitive information, will have to wait a few more days to find out if he’ll be released on bail. After a two-day hearing, the justice overseeing the case said he needs more time to reflect on the evidence and willRead More →

On Wednesday morning, with less than two weeks remaining in the federal campaign, Andrew Scheer worried aloud about MS-13, the notorious Salvadoran-American criminal gang. The Conservative leader stood near Roxham Road in southern Quebec, where asylum seekers crossing from the United States have forced the federal government to establish an unofficialRead More →

Conservative Leader Andrew Scheer is registered with the U.S. Selective Service System, the federal agency that administers that country’s military draft, a party spokesperson confirmed Friday. Scheer confirmed Thursday that he is a dual Canada-U.S. national — his father was born in the U.S. — but said he is in the process of renouncingRead More →

Conservative Leader Andrew Scheer is promising that, if he’s elected, he’ll review the so-called “stress test” to help first-time homebuyers get approved for mortgages and allow people to take out longer mortgages for lower monthly payments. The stress test, introduced by the Office of the Superintendent of Financial Institutions (OSFI) in January 2018,Read More →

The Conservatives were forced Tuesday to remove two social media posts claiming the RCMP had confirmed it was investigating Liberal Leader Justin Trudeau over the SNC-Lavalin affair. The tweets came shortly after RCMP Commissioner Brenda Lucki held a press conference in Ottawa to discuss the arrest of Cameron Ortis, the director general ofRead More →

The House of Commons will review all MP websites after an investigation by CBC News revealed that dozens of them have trackers that can be used to target advertising to people who have visited the sites. Heather Bradley, spokeswoman for the House of Commons, said there are no rules specifically aboutRead More →

A Canadian pharmaceutical lobby group and 16 of its members have filed a lawsuit against Ottawa’s overhaul to how it regulates the costs of patented medicines. Health Canada announced long-awaited amendments last month to patented medicine regulations, which include allowing the arm’s-length Patented Medicine Prices Review Board (PMPRB) to considerRead More →